Weight Loss Drug Market Competition
This is a Chicago news story, published by CNBC, that relates primarily to Abridge news.
Chicago news
For more Chicago news, you can click here:
more Chicago newsAbridge news
For more Abridge news, you can click here:
more Abridge newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsCNBC news
For more news from CNBC, you can click here:
more news from CNBCAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
weight loss drug market. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest weight loss market news, weight loss drug space news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
blockbuster weight loss drug marketCNBC
•Health
Health
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
86% Informative
Companies big and small are vying for a slice of the weight loss drug space.
Some analysts estimate the market could be worth more than $150 billion a year by the end of the decade .
The annual American Diabetes Association conference in Chicago showcased results on obesity injections, pills and other therapies this past weekend .
Abridge uses artificial intelligence to draft clinical notes in real time as doctors consensually record their visits with patients.
Abridge has now announced it closed a $300 million funding round led by Andreessen Horowitz , with participation from Khosla Ventures .
The company earned a spot on CNBC 's Disruptor 50 list this year .
VR Score
87
Informative language
87
Neutral language
48
Article tone
semi-formal
Language
English
Language complexity
54
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
8
Source diversity
6
Affiliate links
no affiliate links